(3-乙基苯基)-肼盐酸盐 | 60481-49-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: (3-乙基苯基)-肼盐酸盐
• 英文名称: 3-ethylphenylhydrazine hydrochloride
• 英文别名: (3-Ethylphenyl)hydrazine hydrochloride；(3-ethylphenyl)hydrazine;hydrochloride
• CAS: 60481-49-4
• 化学式: C₈H₁₂N₂*ClH
• 分子量: 172.658
• InChiKey: JWJSWCNKBBQJMP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.96
• 重原子数：
  11.0
• 可旋转键数：
  2.0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  38.05
• 氢给体数：
  2.0
• 氢受体数：
  2.0

反应信息

• 作为反应物：
  描述：

  4-(二甲基氨基)环己酮盐酸盐 、 (3-乙基苯基)-肼盐酸盐 在 sodium hydroxide 作用下， 以 乙醇 为溶剂， 生成 (5-ethyl-1,2,3,4-tetrahydro-carbazol-3-yl)-dimethyl-amine
  参考文献：
  名称：

  3-Hydroxy carbazole derivatives

  摘要：

  3-(取代氨基)-1,2,3,4-四氢咔唑烯通过将适当的4-取代氨基环己酮与苯基肼反应制备，通过将3-(磺酸酯氧基)-1,2,3,4-四氢咔唑烯与适当的取代胺反应制备，或者通过还原适当的3-(酰胺基)-1,2,3,4-四氢咔唑烯来制备。本发明的3-(取代氨基)-1,2,3,4-四氢咔唑烯具有镇痛和精神活性。此外，其中一些化合物还具有抗组胺活性。

  公开号：

  US04062864A1

文献信息

• Continuous Flow Process For the Synthesis of Phenylhydrazine Salts and Substituted Phenylhydrazine Salts
  申请人：SHANGHAI HYBRID-CHEM TECHNOLOGIES

  公开号：US20190152896A1

  公开（公告）日：2019-05-23

  The present invention provided a continuous flow process for the synthesis of phenylhydrazine salts and substituted phenylhydrazine salts. Diazotization, reduction, acidic hydrolysis and salifying with acids are innovatively integrated together. Using acidic liquids of aniline or substituted aniline, diazotization reagents, reductants and acids as raw materials, phenylhydrazine derivative salts is obtained through the synthesis process, which is a three-step continuous tandem reaction including diazotization, reduction, acidic hydrolysis and salifying. The described synthesis process is a kind of integrated solutions, which is carried out in an integrated reactor. The feed inlets of the integrated reactor are continuously filled with raw materials. In the integrated reactor, diazotization, reduction, acidic hydrolysis and salifying are carried out continuously and orderly, and phenylhydrazine salts or substituted phenylhydrazine salts is obtained in the outlet of the integrated reactor without interruption. The total reaction time is no more than 20 min.

  本发明提供了一种连续流程，用于合成苯肼盐和取代苯肼盐。重氮化、还原、酸性水解和酸化与酸类创新地集成在一起。使用苯胺或取代苯胺的酸性液体、重氮化试剂、还原剂和酸类作为原料，通过合成过程获得苯肼衍生物盐，这是一个包括重氮化、还原、酸性水解和酸化的三步连续串联反应。所述的合成过程是一种集成解决方案，是在一个集成反应器中进行的。集成反应器的进料口连续填充原料。在集成反应器中，重氮化、还原、酸性水解和酸化被连续有序地进行，苯肼盐或取代苯肼盐在集成反应器的出口处获得，没有中断。总反应时间不超过20分钟。
• 3-Amido-1,2,3,4-tetrahydrocarbazoles
  申请人：Sterling Drug Inc.

  公开号：US03959309A1

  公开（公告）日：1976-05-25

  3-(Substituted-amino)-1,2,3,4-tetrahydrocarbazoles are prepared by reacting appropriate 4-substituted-aminocyclohexanones with a phenylhydrazine, by reacting a 3-(sulfonyloxy)-1,2,3,4-tetrahydrocarbazole with an appropriate substituted amine, or by reduction of an appropriate 3-(acylamino)-1,2,3,4-tetrahydrocarbazole. The 3-(substituted-amino)-1,2,3,4-tetrahydrocarbazoles of this invention have analgetic and psychotropic activities. Moreover, certain of these compounds also have antihistaminic activity.

  通过将适当的4-取代氨基环己酮与苯基肼反应，通过将3-(磺酰氧基)-1,2,3,4-四氢咔唑与适当的取代胺反应，或者通过还原适当的3-(酰胺基)-1,2,3,4-四氢咔唑，可以制备3-(取代氨基)-1,2,3,4-四氢咔唑。本发明的这些3-(取代氨基)-1,2,3,4-四氢咔唑具有镇痛和精神活性。此外，这些化合物中的某些化合物还具有抗组胺活性。
• Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors
  申请人：Mathias Paul John

  公开号：US20060035922A1

  公开（公告）日：2006-02-16

  A compound of formula (I), or a pharmaceutically acceptable salt and/or solvate (including hydrate) thereof; and the use of a compound of formula (I) in the treatment of a TNF-mediated disease, disorder, or condition, or a p38-mediated disease, disorder, or condition, in particular the allergic and non-allergic airways diseases, more particularly obstructive or inflammatory airways diseases, preferably chronic obstructive pulmonary disease.

  公式（I）的化合物，或其药学上可接受的盐和/或溶剂合物（包括水合物）；以及公式（I）的化合物在治疗TNF介导的疾病、疾病或症状，或p38介导的疾病、疾病或症状中的用途，特别是过敏和非过敏的呼吸道疾病，更特别是梗阻性或炎症性呼吸道疾病，最好是慢性阻塞性肺病。
• Triazolopyridinylsulfanyl Derivatives As P38 Map Kinase Inhibitors
  申请人：Mathias John Paul

  公开号：US20090239899A1

  公开（公告）日：2009-09-24

  A compound of formula (I), or a pharmaceutical acceptable salt and/or solvate (including hydrate) thereof; and the use of a compound of formula (I) in the treatment of a TNF-mediated disease, disorder, or condition, or a p38-mediated disease, disorder, or condition, in particular the allergic and non-allergic airways diseases, more particularly obstructive or inflammatory airways diseases, preferably chronic obstructive pulmonary disease.

  公式（I）的化合物，或其药学上可接受的盐和/或溶剂（包括水合物）;以及在治疗TNF介导的疾病，紊乱或状况，或p38介导的疾病，紊乱或状况中使用公式（I）的化合物，特别是过敏和非过敏的气道疾病，更特别是阻塞性或炎症性气道疾病，最好是慢性阻塞性肺病。
• Continuous flow process for the synthesis of phenylhydrazine salts and substituted phenylhydrazine salts
  申请人：SHANGHAI HYBRID—CHEM TECHNOLOGIES

  公开号：US11040938B2

  公开（公告）日：2021-06-22

  The present invention provided a continuous flow process for the synthesis of phenylhydrazine salts and substituted phenylhydrazine salts. Diazotization, reduction, acidic hydrolysis and salifying with acids are innovatively integrated together. Using acidic liquids of aniline or substituted aniline, diazotization reagents, reductants and acids as raw materials, phenylhydrazine derivative salts is obtained through the synthesis process, which is a three-step continuous tandem reaction including diazotization, reduction, acidic hydrolysis and salifying. The described synthesis process is a kind of integrated solutions, which is carried out in an integrated reactor. The feed inlets of the integrated reactor are continuously filled with raw materials. In the integrated reactor, diazotization, reduction, acidic hydrolysis and salifying are carried out continuously and orderly, and phenylhydrazine salts or substituted phenylhydrazine salts is obtained in the outlet of the integrated reactor without interruption. The total reaction time is no more than 20 min.

  本发明提供了一种合成苯肼盐和取代苯肼盐的连续流工艺。重氮化、还原、酸性水解和酸盐化被创新性地整合在一起。以苯胺或取代苯胺的酸性液体、重氮化试剂、还原剂和酸为原料，通过重氮化、还原、酸性水解和盐化三步连续串联反应的合成工艺，获得苯肼衍生物盐。所述合成工艺是一种一体化解决方案，在一体化反应器中进行。集成反应器的进料口连续注入原料。在一体化反应器中，重氮化、还原、酸性水解和盐化连续有序地进行，在一体化反应器的出口处不间断地得到苯肼盐或取代苯肼盐。总反应时间不超过 20 分钟。